tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
Want to see INTS full AI Analyst Report?

Intensity Therapeutics, Inc. (INTS) Financial Statements

252 Followers

Intensity Therapeutics, Inc. Financial Overview

Intensity Therapeutics, Inc.'s market cap is currently $13.34M. The company's EPS TTM is $1.69; its P/E ratio is -11.99; Intensity Therapeutics, Inc. is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $-1.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -26.00K$ 0.00$ -147.00K$ 0.00$ 0.00
Operating Income$ -11.97M$ -16.59M$ -8.32M$ -7.55M$ -8.01M
EBITDA$ -11.97M$ -16.27M$ -10.09M$ -7.50M$ -7.88M
Net Income$ -11.61M$ -16.27M$ -10.54M$ -7.58M$ -7.90M
Balance Sheet
Cash & Short-Term Investments$ 11.92M$ 2.59M$ 14.78M$ 1.31M$ 4.54M
Total Assets$ 14.10M$ 4.78M$ 17.30M$ 1.76M$ 5.22M
Total Debt$ 110.00K$ 138.00K$ 158.00K$ 4.49M$ 2.34M
Net Debt$ -11.81M$ -2.45M$ -8.40M$ 3.18M$ -2.20M
Total Liabilities$ 2.23M$ 1.86M$ 4.13M$ 16.86M$ 13.90M
Stockholders' Equity$ 11.88M$ 2.92M$ 13.16M$ -15.10M$ -8.68M
Cash Flow
Free Cash Flow$ -9.23M$ -15.22M$ -7.21M$ -5.48M$ -6.83M
Operating Cash Flow$ -9.23M$ -15.22M$ -7.21M$ -5.48M$ -6.83M
Investing Cash Flow$ 0.00$ 6.35M$ -6.02M$ 0.00$ 0.00
Financing Cash Flow$ 18.56M$ 2.90M$ 20.47M$ 2.25M$ 2.05M
Currency in USD

Intensity Therapeutics, Inc. Earnings and Revenue History

Intensity Therapeutics, Inc. Debt to Assets

Intensity Therapeutics, Inc. Cash Flow

Intensity Therapeutics, Inc. Forecast EPS vs Actual EPS